-Reuters
Novavax Confirms Earlier Reporting FDA Advisory Committee Recommends Emergency Use Authorization Of Novavax Covid-19 Vaccine For People Aged 18 Years And Older
Novavax, Inc. (NASDAQ:NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, today announced the U.S. Food and Drug Administration (FDA)
